IL
The startup employs an AI-first methodology to fundamentally transform the drug discovery process, utilizing machine learning algorithms to predict molecular interactions and optimize compound selection. This approach addresses the inefficiencies and high costs associated with traditional drug development, significantly accelerating the timeline from research to market.
Updated 2 months ago
Funding
$600M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup employs an AI-first methodology to fundamentally transform the drug discovery process, utilizing machine learning algorithms to predict molecular interactions and optimize compound selection. This approach addresses the inefficiencies and high costs associated with traditional drug development, significantly accelerating the timeline from research to market.